Another study identified that the upregulation of AKR1C2 is strongly correlated with the pathological stage and has worse prognosis in patients with esophageal squamous cell carcinoma (ESCC) [10]. This evidence concerns the gene AKR1C2 and esophageal squamous cell carcinoma.